Oneness Biotech Co., Ltd. (LUX:ONES)
Luxembourg
· Delayed Price · Currency is EUR · Price in USD 8.60
+0.15 (1.78%)
At close: Mar 6, 2026
Oneness Biotech Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 711 | 1,228 | 2,599 | 2,900 | 3,474 | 2,612 | Upgrade
|
| Market Cap Growth | -35.57% | -52.75% | -10.37% | -16.52% | 33.00% | 752.33% | Upgrade
|
| Enterprise Value | 575 | 1,043 | 2,385 | 2,658 | 3,253 | 2,526 | Upgrade
|
| Last Close Price | 7.41 | 12.85 | 28.77 | 37.42 | 45.71 | 35.06 | Upgrade
|
| PE Ratio | - | - | - | 264.52 | - | - | Upgrade
|
| PS Ratio | 216.87 | 353.46 | 1014.35 | 89.36 | 1664.92 | 2157.53 | Upgrade
|
| PB Ratio | 2.32 | 3.26 | 6.07 | 6.40 | 7.77 | 6.52 | Upgrade
|
| P/TBV Ratio | 2.69 | 3.75 | 7.17 | 7.61 | 9.49 | 8.11 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 792.14 | Upgrade
|
| P/OCF Ratio | - | - | - | - | - | 567.63 | Upgrade
|
| EV/Sales Ratio | 181.06 | 300.04 | 930.60 | 81.91 | 1558.95 | 2086.00 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 377.48 | - | - | Upgrade
|
| EV/FCF Ratio | -42.67 | - | - | - | - | 765.88 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 1.05 | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 2.68 | Upgrade
|
| Net Debt / Equity Ratio | -0.50 | -0.52 | -0.51 | -0.52 | -0.53 | -0.58 | Upgrade
|
| Net Debt / EBITDA Ratio | 10.25 | 9.71 | 10.89 | -33.66 | 10.56 | 15.61 | Upgrade
|
| Net Debt / FCF Ratio | 11.40 | 16.73 | 14.33 | 8.04 | 19.58 | -70.72 | Upgrade
|
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.07 | 0.00 | 0.00 | Upgrade
|
| Inventory Turnover | 0.74 | 0.46 | 0.46 | 2.30 | 0.32 | 0.22 | Upgrade
|
| Quick Ratio | 35.83 | 38.90 | 36.45 | 38.73 | 50.46 | 57.46 | Upgrade
|
| Current Ratio | 37.04 | 39.87 | 37.23 | 39.47 | 51.21 | 58.15 | Upgrade
|
| Return on Equity (ROE) | -11.42% | -8.45% | -9.00% | 2.43% | -2.96% | -2.49% | Upgrade
|
| Return on Assets (ROA) | -4.02% | -4.68% | -4.43% | -0.96% | -3.53% | -3.76% | Upgrade
|
| Return on Invested Capital (ROIC) | -15.31% | -16.28% | -15.39% | -2.75% | -14.26% | -12.30% | Upgrade
|
| Return on Capital Employed (ROCE) | -7.20% | -8.10% | -7.20% | -1.60% | -5.60% | -4.40% | Upgrade
|
| Earnings Yield | -5.51% | -2.79% | -1.49% | 0.38% | -0.37% | -0.27% | Upgrade
|
| FCF Yield | -1.90% | -0.95% | -0.58% | -1.02% | -0.35% | 0.13% | Upgrade
|
| Dividend Yield | - | - | - | 0.01% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.31% | -0.97% | -0.40% | -3.58% | -6.82% | -42.09% | Upgrade
|
| Total Shareholder Return | -0.31% | -0.97% | -0.40% | -3.57% | -6.82% | -42.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.